Opinion: Early diagnosis, not cancer drug breakthroughs, is the best way to fix the global scourge of breast cancer
Covid-19 news could be nudged out of the spotlight this weekend as the American Society of Clinical Oncology’s annual scientific meeting, this year being held virtually, mobilizes 40,000 people around the world across industry, academia, and government. Breakthroughs will almost certainly be announced.
Among the nearly 5,300 scientific abstracts being presented at the ASCO meeting, only about 10 focus on breast cancer in low- and middle-income countries, even though the death rate from breast cancer in those countries is almost double that of the U.S.
